Klinische Infektionskrankheiten: Open Access

Efficacy of Novel Antiviral Therapies in the Treatment of Severe Acute Respiratory Syndrome

Abstract

Christina Stelios

Severe Acute Respiratory Syndrome (SARS) has posed a significant threat to global public health, causing outbreaks with potentially severe consequences. In the pursuit of effective treatments, researchers and pharmaceutical companies have been exploring novel antiviral therapies that show promise in mitigating the impact of SARS. Severe Acute Respiratory Syndrome, commonly known as SARS, is a viral respiratory illness that gained international attention in the early 2000s due to its potential for rapid spread and severe health consequences. The disease is caused by the SARS coronavirus, specifically referred to as SARS-CoV. SARS is a viral respiratory illness caused by the coronavirus SARS-CoV. The hallmark symptoms include fever, cough and difficulty breathing and in severe cases, it can lead to pneumonia, respiratory failure and death. Given its potential for rapid transmission, SARS outbreaks demand swift and effective interventions.